The cost-effectiveness of routine histologic examination

American Journal of Clinical Pathology

Volumn 110, Issue 3, 1998, Pages 391-396

  Raab, Stephen S ^a  

^a NONE

Author keywords

Cancer; Cost analysis; Diagnosis; Pathology

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; GASTRITIS; HEALTH CARE COST; HISTOPATHOLOGY; INGUINAL HERNIA; INTERVERTEBRAL DISK HERNIA; LIFE EXPECTANCY; LYMPHOMA; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0031785017     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.3.391     Document Type: Article

References (30)

1. Netser JC, Robinson RA, Smith RJ, et al. Value-based pathology: a cost-benefit analysis of the examination of routine and nonroutine tonsil and adenoid specimens. Am J Clin Pathol. 1997;108:158-165.
2. Gold MR, Siegel JE, Russell LB, et al, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
3. Fechner RE. Value-based surgical pathology: a valuable concept. Am J Clin Pathol 1997;108:123-126.
4. Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J. 1993;148:913-917.
5. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253-1258.
6. Russell LB. Some of the tough decisions required by a national health plan. Science. 1989;246:892-896.
7. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia, PA: Saunders; 1980:12-36.
8. Kassan MA, Munoz E, Laughlin A, et al. Value of routine pathology in herniorrhaphy performed upon adults. Surg Gynecol Obstet. 1986;163:518-522.
9. Owens DK, Sanders GD, Harris RA, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1-12.
10. Raab SS, Hornberger J. The effect of a patient's risk-taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions. Chest. 1997;111:1583-1590.
11. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations. Can Med Assoc J. 1992;146:473-481.
12. Naylor CD, Williams HI, Basinski A, et al. Technology assessment and cost-effectiveness analysis: misguided guidelines? Can Med Assoc J. 1993;148:921-924.
13. Laupacis A, Feeny D, Detsky AS, et al. Tentative guidelines for using clinical and economic evaluations revisited. Can Med Assoc J. 1993;148:927-929.
14. Wolkomir AF, Barone JE, Moser RL. Selective microscopic examination of gallbladders, hernia sacs and appendices. Am Surg. 1991;57:289-292.
15. Boutin P, Hogshead H. Surgical pathology of the intervertebral disc: is routine examination necessary? Spine. 1992;17:1236-1238.
16. Cornell WB, Levin HS. The inguinal hernia sac: trash or treasure? Anatomic Pathology II Check Sample, APII-92. Chicago, Ill: American Society of Clinical Pathologists; 1993:17(4).
17. DeLong WH, Grignon DJ. Pathologic findings in ribs removed at the time of radical nephrectomy for renal cell carcinoma. Int J Surg Pathol. 1994;1:177-180.
18. Raab SS, Slagel DD, Robinson RA. The utility of the histologic examination of tissue removed during elective joint replacement: a preliminary assessment. J Bone Joint Surg. 1998;80A:331-335. Abstract.
19. Daneshbod K, Bhutta R, Sodagar R. Pathology of tonsils and adenoids: a study of 15,120 cases. Ear Nose Throat J. 1980;59:53-54.
20. Sodagar R, Molhallati E. Necessity of routine pathological examination on tonsils. Ear Nose Throat J. 1972;51:229-230.
21. Kaplan RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev. 1993;19(suppl A):85-96.
22. Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Cancer. 1994;73:2087-2098.
23. Schmitt R. Quality of life issues in lung cancer: new symptom management strategies. Chest. 1993;103(suppl):51S-55S.
24. Weibel E. Pathological findings of clinical value in tonsils and adenoids. Acta Otolaryngol (Stockh). 1965;60:331-338.
25. Yarington LT, Smith GS, Benzmiller JA. Value of the histologic examination of tonsils: a report of isolated tonsillar sarcoidosis. Arch Otolaryngol. 1967;85:680-681.
26. Erwin SA. Unsuspected sarcoidosis of the tonsil. Otolaryngol Head Neck Surg. 1989;100:245-247.
27. Wilson R, Sweatman M, Mackay IS, et al. Adenoidal tissue as an aid to the diagnosis of sarcoidosis in childhood. Thorax. 1986;41:66-67.
28. Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med. 1989;28:299-308.
29. Carr-Hill RA. Background material for the workshop on QALYs. Soc Sci Med. 1989;3:469-477.
30. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102-109.